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In the absence of overt infection, the systemic inflammatory response is increasingly recognised as a pathogenetic factor in the circulatory dysfunction of advanced cirrhosis.
Patients with Child-Pugh Class C cirrhosis and ascites demonstrate an increased frequency of bacterial translocation, circulating bacterial DNA and raised plasma levels of lipopolysaccharide binding protein (LBP) [1, 2, 3, 4, 5] . Bacterial translocation is associated with nitric oxide overproduction in the mesenteric vasculature of cirrhotic rats, which appears to aggravate the arterial vasodilatation [6] . In humans with end stage liver disease there is increased mesenteric lymph node tumour necrosis factor-alpha (TNF-α) expression, and increased LBP levels are accompanied by greater circulating levels of inflammatory mediators and a more pronounced circulatory dysfunction [5, 7] . The exaggerated immunohaemodynamic derangement is reversed by the administration of norfloxacin [5, 8] .
Moreover, long-term prophylactic antibiotics reduce the incidence of hepatorenal syndrome and improve survival, independent of the prevention of infection [9] . It is therefore postulated that bacterial translocation and the secondary systemic response exacerbate the pre-existing portal hypertensive syndrome, with implications for hepatic function.
Markers of systemic inflammation have been linked with prognosis in patients in this setting.
Hospitalised cirrhotics with the systemic inflammatory response syndrome (SIRS) have more severe hepatic encephalopathy, and are more likely to develop hepatorenal syndrome and have non reversible renal dysfunction [10, 11, 12] . Moreover, the presence of SIRS is associated with greater in hospital mortality [10, 11, 12] . However, the individual parameters of SIRS may be influenced by the clinical features of cirrhosis, and the presence or absence of SIRS does not always correlate with the systemic inflammatory response in these patients [13, 14] . An alternative marker of systemic inflammation, c-reactive protein (CRP) has been shown to be a superior prognostic marker if persistently elevated [14] . Yet, CRP is
This article is protected by copyright. All rights reserved. synthesised by the liver and is only marginally increased even in patients with active infection [14] . Furthermore, CRP is influenced by other factors such as body mass index, weight loss, smoking, active alcohol consumption and diabetes [15] .
The studies examining SIRS and CRP as prognostic markers in cirrhosis included patients with decompensated disease and a high prevalence of overt infection or acute alcoholic hepatitis [10, 11, 12, 13] . Only a single study has evaluated the usefulness of a marker of subclinical inflammation in predicting prognosis in stable patients [16] . Biyik et al found that in a population of cirrhotics with less advanced disease (mean MELD score 10 and child pugh score 7) a greater neutrophil-to-lymphocyte ratio (NLR) was associated with an increased risk of long-term death [16] . Neutrophilia occurs in chronic inflammation and lymphopenia accompanies malnutrition; increasing NLR has been shown to predict outcome in various other disease processes including cardiac disease, malignancy and renal failure [17, 18, 19, 20] . To our knowledge the utility of the NLR as a predictor of death in stable patients with end stage cirrhosis has not been examined previously. Our aim was therefore to determine whether the NLR, a simple marker of chronic systemic inflammation, is predictive of mortality in patients with end stage cirrhosis listed for liver transplantation.
Methods
This was a single centre study of 570 consecutive adults listed for first elective single-organ liver transplantation for chronic liver disease between January 2007 and June 2011. Patients transplanted for acute liver failure were not included, and no patient had end stage renal disease requiring renal replacement therapy.
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Institutional approval was obtained (Clinical Audit department, Queen Elizabeth Hospital; reference CAB-05300-13). Written patient consent was not required.
Patients were identified from a prospectively collected database. The following variables at time of listing for liver transplantation were recorded: age, gender, weight, height, aetiology of liver disease, presence of diabetes mellitus, previous variceal haemorrhage, refractory ascites and transjugular intra-hepatic porto-systemic shunt (TIPSS); prescription of nonselective betablockers, prophylactic antibiotics (the indication for antibiotics was usually the secondary prophylaxis of spontaneous bacterial peritonitis, or end-stage liver disease, and was clinician dependent) and immunosuppressive medications (the indication for immunosuppressive medications was autoimmune disease, predominantly autoimmune liver disease and inflammatory bowel disease); laboratory data (serum bilirubin, albumin, international normalised ratio (INR), neutrophil count, lymphocyte count, creatinine, serum sodium).
Refractory ascites and type 2 hepatorenal syndrome were defined according the International Ascites Club criteria [21, 22] . The MELD (Model for End Stage Liver Disease) score was determined [23] . The UK Score for Patients with End-Stage Liver Disease (UKELD), a recently devised scoring system that incorporates serum sodium in addition to the MELD variables used routinely in the UK to prioritise graft allocation, was also calculated [24] . 
Statistical analyses
Normally distributed continuous variables and non-parametric continuous variables were compared using the Student's t-test and Mann-Whitney test, respectively. Chi-squared analysis or Fisher's exact test were used for comparison of categorical data. Correlations were determined by Spearman's rank test. 
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This article is protected by copyright. All rights reserved. then generated to assess the accuracy of variables in predicting death by 3-months. To examine the impact of the addition of NLR to the MELD and UKELD scores competing risk Cox regression of variables transformed into their natural logarithms provided regression coefficients. Concordance statistics (c-statistics) were compared using the method described by Hanley and McNeil [28] . All patients censored prior to the specified time point were excluded from these analyses.
Data was analysed using the SPSS 21 package (SPSS Inc, Chicago, IL, USA) except the competing risk analyses, which were performed using Stata 13.1 (Stat Corp, College Station, Texas). All values are expressed as mean and standard deviation (SD), median and interquartile range (IQR) and number and percent (%) as appropriate. P<0.05 was considered statistically significant at all times.
Results
Characteristics of the patients at time of listing for liver transplantation are outlined in Table   1 . The mean age was 54.1 (SD 9.9) years and the male to female ratio was 1.8:1. The mean listing MELD score was 15 (SD 5).
The median listing neutrophil count was 3.2 (IQR 2.2-4.5) x10 9 /l. Ninety-six patients (17.0%) had a neutrophil count below the reference range, and 27 patients (4.8%) had a neutrophil count above. The median listing lymphocyte count was 1.1 (0.7-1.5) x10 9 /l. Two hundred and twenty-five patients (39.8%) and 1 patient (0.2%) had a lymphocyte count below and above the normal range, respectively. The median NLR was 2.9 (IQR 1.9-4.7).
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Parameters associated with NLR
There was no relationship between listing NLR and age (r=0.030, p=0.473) or gender (male, 
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This article is protected by copyright. All rights reserved. NSBB (2.2 (IQR 2.0-4.5)) compared to patients not prescribed NSBB (2.9 (IQR 1.9-4.7), p=0.893). Variables associated with wait-list death on univariate analysis are presented in Table 2 . A higher neutrophil count (p<0.001) and lower lymphocyte count (p=0.001) were predictors of mortality within 1 year of listing. The greater the NLR, the greater the risk of death (p<0.001).
NLR and wait-list mortality
In a multivariate competing risk Cox model, NLR was independently associated with waitlist mortality (HR 1.10; 95% CI 1.05-1.15, p<0.001, Table 3 and Figure 2 ). Other variables associated with death were MELD score (p=0.007) and refractory ascites (p=0.010). The higher the NLR, the lower the likelihood of transplantation (p=0.023). Substitution of MELD with UKELD in the multivariate model did not affect the statistical relationship between NLR and mortality (HR 1.08; 95% CI 1.03-1.13, p=0.001, model not shown). NLR remained independently associated with wait-list death in the following subgroups of patients: absence of hepatocellular carcinoma, presence of hepatocellular carcinoma, refractory ascites, no refractory ascites, listing MELD ≥18, listing MELD <18 (Table 4 ).
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NLR and 3-month mortality
263 patients (46.1%) and 44 patients (7.7%) were transplanted or had died by 3-months after listing. The listing neutrophil count was higher in patients who died (dead, 4.6 (2.6-7.0); alive, 3.1 (2.1-4.0); median (IQR), p<0.001), and the listing lymphocyte count was lower (dead, 1.0 (0.6-1.3); alive, 1.0 (0.7-1.5); median (IQR), p=0.018). The median listing NLR of the non surviving patients was 4.7 (IQR 2.8-8.8) and for the surviving patients was 2.8 (IQR 2.0-4.5, p<0.001, Figure 3 ).
The proportion of patients with a listing NLR <2, 2-4.9, and ≥5 who had died within 3months was 3%, 13.8% and 37.3%, respectively (p<0.001). After adjusting for MELD, increasing increments of NLR were associated with greater 3-month mortality (NLR <2, OR 1.00; NLR 2-4.9, OR 3.17 (95% CI 0.70-14.37); NLR ≥5, OR 6.02 (95% CI 1.28-28.41), p=0.043).
The c-statistic for the listing NLR for predicting death by 3-months was 0.709 (95% CI 0.624-0.794). The addition of NLR to MELD increased the c-statistic from 0.768 (95% CI 0.689-0.847) to 0.792 (95% CI 0.716-0.868, p=0.579). The addition of NLR to UKELD did not affect the c-statistic for predicting 3-month death (UKELD alone, 0.821 (95% CI 0.749-0.892); UKELD and NLR, 0.820 (95% CI 0.750-0.890).
Discussion
In this large single centre study we have examined for the first time the ability of the blood NLR, a simple marker of systemic inflammation, to predict prognosis in stable patients with end stage cirrhosis listed for liver transplantation. We have made two important observations. Firstly, the NLR increases with increasing severity of liver failure. We observed that the NLR
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This article is protected by copyright. All rights reserved. correlated positively with jaundice, ascites and MELD, and the higher the NLR the greater was the risk of death. This supports the hypothesis that subclinical inflammation is a pathogenetic factor in advanced liver disease. Secondly, the NLR is a useful prognostic indicator in patients listed for liver transplantation. In a multivariate competing risk Cox model, listing NLR predicted wait-list mortality independent of the MELD score.
In contrast to previous studies of markers of systemic inflammation in advanced cirrhosis, our findings were made in the absence of acute decompensation precipitated by for example infection or acute alcoholic hepatitis [10, 11, 12, 14] . In stable cirrhotic patients the prevalence of circulating bacterial DNA has been reported to be approximately 40% [29, 30] . Low dose endotoxaemia without clinical signs or symptoms is associated with a systemic inflammatory response, and induces a rise in blood neutrophil count and fall in total lymphocyte count [31] .
Therefore, in cirrhosis the increased NLR may be an indicator of subclinical endotoxaemia.
Lymphocytopenia is also a well recognised sequelae of malnutrition. The high prevalence of lymphocytopenia in our patients, and the association of a lower lymphocyte count with mortality, may have at least in part been a consequence of poor nutritional status [20, 32] .
A greater listing NLR was associated with more severe liver failure, as demonstrated by a higher serum bilirubin level, INR and MELD score. Moreover, an increasing NLR was related to the severity of ascites, hyponatraemia and renal dysfunction. Our study does not clarify whether the systemic inflammatory response contributes to the hepatic and circulatory dysfunction of cirrhosis, or is a secondary phenomenon and a surrogate marker of advanced disease. However, the previous observation that norfloxacin administration in ascitic patients increased vascular resistance, in the context of normalisation of plasma LBP and reduced cytokine levels, is consistent with an active role [5, 8] . Further support for this theory is
This article is protected by copyright. All rights reserved. provided by Fernandez et al's randomised controlled trial in which long-term prophylactic antibiotics reduced the incidence of hepatorenal syndrome and improved survival, independent of the prevention of infection [9] .
Blood NLR has been linked with outcome in other aspects of liver disease. In patients with hepatocellular carcinoma, the NLR correlates with tumour stage, and a greater NLR has been shown to be related to non response to treatment, tumour recurrence, all-cause mortality and post liver transplantation death [33, 34, 35, 36, 37] . Similarly, in patients receiving chemotherapy or undergoing resection of colorectal liver metastasis, a higher NLR was associated with an increased mortality risk [38, 39] . Only one paper has examined the role of NLR for staging severity of liver disease: in patients undergoing liver biopsy for a clinical suspicion of non-alcoholic fatty liver disease the NLR was predictive of the presence of steatohepatitis and fibrosis [40] .
The majority of deaths in this series were as a result of liver failure or sepsis. We hypothesise that the increased NLR in our patients was a sign of subclinical endotoxaemia, and that the relationship between increasing NLR and death reflected the role that the systemic inflammatory response plays in the hepato-circulatory dysfunction of advanced liver disease.
It should be mentioned that blood NLR has also been shown to be a marker of worse outcome in other disease processes where chronic inflammation has pathogenetic significance. In particular, the NLR has recently emerged as a risk stratification tool in cardiovascular disease. An elevated NLR is associated with arterial stiffness and the coronary artery calcification score, and is a poor prognostic indicator in acute coronary syndrome and stable coronary artery disease [17] . It is postulated that neutrophils have a causal link in such
conditions. Following on from this, in patients scheduled for angiography the blood neutrophil count outperformed CRP as a predictor of cardiovascular mortality [41] .
The main limitation of this study is the NLR was calculated from a single blood sample taken at the time of listing for transplantation. It is possible that low grade infection could have been undiagnosed, and impacted on the association between NLR and death. However, our unit has a high suspicion for infection in cirrhotic patients, and infection is a contraindication to activation on the transplant waiting list. Moreover, the incidence of death increased linearly over a prolonged follow-up time period.
The clinical implications of our findings are two-fold. Firstly, NLR is predictive of liver transplant wait-list mortality, independent of current scoring systems. In an era of organ shortage and growing wait-list death tools to optimise wait-list prioritisation and organ allocation are necessary. Our findings support the use of the NLR as a prognostic marker in this setting. Secondly, interventions that modify the systemic inflammatory response are likely to be beneficial. Prophylactic antibiotics in high risk individuals may reduce the incidence of circulatory complications and prolong survival to transplantation [9] .
In conclusion, in this large single centre study we have shown for the first time that a simple and readily available marker of systemic inflammation, the NLR, is an independent predictor of mortality in patients with liver failure listed for liver transplantation. Our findings suggest a new prognostic marker to aid wait-list prioritisation and organ allocation, and add weight to the hypothesis that low grade endotoxaemia and a systemic inflammatory response play a pathogenetic role in end stage cirrhosis.
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